Published Date: 02 Feb 2024
B-cell malignancies, B-cell treatments associated with longer duration of infection.
Read Full NewsAs cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges—particularly anxiety and depression, which affect about 30% of this population. Emotional distress is ...
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, ...
The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...
1.
MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information
2.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
3.
The importance of breast cancer screening
4.
Many Americans unaware of links between HPV and cancers, poll reveals
5.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
1.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
2.
Oncologic Emergencies: Diagnosis and Treatment
3.
Tumor Evolution: Signaling, Cancer Cell Plasticity, and Intratumor Heterogeneity
4.
Vaccines that can help prevent cancer
5.
Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation